TABLE 2.
The causality of blood lead level and AD risk by two-sample MR analysis using the data of EFO_0000249.
| SNP | Position | Effect allele | GWAS of blood lead level |
GWAS of AD |
Model | MR analysis |
Heterogeneity test |
Horizontal pleiotropy |
|||||
| Beta | P-value | Beta | P-value | Beta | P-value | Cochran’s Q | P-value | Intercept | P-value | ||||
| rs76153987 | chr3:9214817 | T | −0.195 | 4 × 10–6 | −0.036 | 0.4025 | |||||||
| IVW | 0.242 | 0.0046 | 3.297 | 0.51 | |||||||||
| rs116864947 | chr7:11705786 | T | −0.431 | 3 × 10–7 | 0.128 | 0.0333 | |||||||
| rs6462018 | chr7:27519118 | G | −0.084 | 4 × 10–6 | −0.005 | 0.8136 | –0.026 | 0.385 | |||||
| rs798338 | chr7:78287721 | A | −0.111 | 4 × 10–6 | −0.015 | 0.4901 | |||||||
| WME | 0.220 | 0.0059 | 2.269 | 0.52 | |||||||||
| rs10121150 | chr9:113369415 | C | −0.143 | 3 × 10–8 | 0.069 | 0.0183 | |||||||